The carrier state in muscular dystrophy of the Duchenne type
- 11 October 1965
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 194 (2), 130-134
- https://doi.org/10.1001/jama.194.2.130
Abstract
Serum creatine phosphokinase (CPK) levels were studied under basal conditions in 75 female relatives of patients with muscular dystrophy of Duchenne type to determine the reliability of this procedure in detecting the carrier state. The subjects were 1st classified by their genetic history into 3 groups: definite, probable, and possible carriers. The elevations in CPK levels in these 3 groups were 79%, 50%, and 45%, respectively, indicating the possibility of detecting many of the carriers of this hereditary disease. However, application of the procedure to genetic counseling requires recognition of its limitations. The observations, also, suggest that in 24% of the families, fresh mutations could have accounted for the disease.This publication has 9 references indexed in Scilit:
- Creatine phosphokinase and other serum enzyme activity after controlled exerciseNeurology, 1964
- Decreased Body Potassium in Nondystrophic Relatives of Patients with Muscular DystrophyNew England Journal of Medicine, 1964
- Changes in serum enzyme levels after exercise in trained and untrained subjectsJournal of Applied Physiology, 1962
- SEX CHROMATIN AND GENE ACTION IN MAMMALIAN X-CHROMOSOME1962
- SERUM ENZYMES AND GENETIC CARRIERS IN MUSCULAR DYSTROPHY1960
- Creatine and Creatine Kinase MeasurementJournal of Biological Chemistry, 1959
- MUTATION IN THE SEX‐LINKED RECESSIVE TYPE OF MUSCULAR DYSTROPHY. A POSSIBLE SEX DIFFERENCEAnnals of Human Genetics, 1956
- STUDIES IN DISEASES OF MUSCLEArchives of Neurology & Psychiatry, 1943
- Untersuchungen angeblich gesunder Verwandter von MuskeldystrophikernZeitschrift für die gesamte Neurologie und Psychiatrie, 1930